Compare ADMA Biologics Inc (ADMA) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Energy Select Sector SPDR Fund — how do they compare? ADMA Biologics Inc trades at $9.28 (market cap $2.13B), while Energy Select Sector SPDR Fund trades at $55.32. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | XLE | |
|---|---|---|
Market Cap | $2.13B | — |
Sector | Health | — |
52-Week High | $20.38 | $62.57 |
52-Week Low | $7.60 | $42.12 |
Enterprise Value | $2.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
XLE trades at $53.13, down 0.17% on the day, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. The ETF has gained 21% year-to-date, ranking among top-performing sector SPDRs according to ETF Trends on July 2, 2026. Recent news highlights oil price volatility and geopolitical developments affecting energy sector performance, while a dividend of $0.38 is scheduled for June 2026.
Outlook remains mixed with technical weakness offset by strong YTD performance. Investment opportunity exists for investors seeking energy sector exposure amid ongoing oil market volatility, though risks include geopolitical tensions and potential Federal Reserve rate hikes that could pressure the sector. The neutral oscillator reading suggests potential for near-term stabilization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
